The Journal of Immunology, Vol 141, Issue 6 1919-1924, Copyright © 1988 by American Association of Immunologists

ARTICLES

Triggering of co-mitogenic signals in T cell proliferation by anti-LFA- 1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies

AC Carrera, M Rincon, F Sanchez-Madrid, M Lopez-Botet and MO de Landazuri
Servicio de Inmunologia Hospital de la Princesa, Madrid, Spain.

Proliferative T cell responses were elicited in a comitogenic assay when purified mAb against CD 18, CD11a, LFA-3, and CD7 were immobilized onto solid plastic surfaces together with submitogenic doses of mAb against the CD3 complex. The proliferative response was associated to the production of IL-2 and to the expression of IL-2R. We explored the possibility that a second signal provided by either PMA or a Ca2+ ionofore could replace the anti-CD3 mAb in the comitogenic assay. Interestingly, our data clearly indicate that PMA but not the ionofore was capable of mediating the co-mitogenic effect in conjunction with solid-bound mAb (CDw18, CD11a, LFA-3, and CD7). We also demonstrate that the mAb (anti-CD4 and anti-CD2) which have been previously described as co-mitogenic in combination with anti-CD3 are capable of eliciting this activating signal in the presence of PMA. These data indicate that mAb to certain cell surface differentiation Ag that in soluble form inhibit T cell function such as LFA-1, LFA-3, and CD2 can under appropriate conditions induce co-mitogenic signals on T cells. Our results support the hypothesis that several cell surface differentiation Ag may participate in conjunction with the T3-Ti complex in the transmembrane signal transduction leading to T cell activation.

This article has been cited by other articles:

				K. Ogata, K. Nakamura, N. Yokose, H. Tamura, M. Tachibana, O. Taniguchi, R. Iwakiri, T. Hayashi, H. Sakamaki, Y. Murai, et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome Blood, December 1, 2002; 100(12): 3887 - 3896. [Abstract] [Full Text] [PDF]

				C. S. Heinly, G. D. Sempowski, D. M. Lee, D. D. Patel, P. M. McDermott, R. M. Scearce, C. B. Thompson, and B. F. Haynes Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice Int. Immunol., February 1, 2001; 13(2): 157 - 166. [Abstract] [Full Text] [PDF]

				S. D. Lyman, S. Escobar, A.-M. Rousseau, A. Armstrong, and W. C. Fanslow Identification of CD7 as a Cognate of the Human K12 (SECTM1) Protein J. Biol. Chem., February 4, 2000; 275(5): 3431 - 3437. [Abstract] [Full Text] [PDF]

				R. D. M. Soede, M. H. E. Driessens, L. Ruuls-Van Stalle, P. E. M. Van Hulten, A. Brink, and E. Roos LFA-1 to LFA-1 Signals Involve {zeta}-Associated Protein-70 (ZAP-70) Tyrosine Kinase: Relevance for Invasion and Migration of a T Cell Hybridoma J. Immunol., October 15, 1999; 163(8): 4253 - 4261. [Abstract] [Full Text] [PDF]

				D. M. Lee, H. F. Staats, J. S. Sundy, D. D. Patel, G. D. Sempowski, R. M. Scearce, D. M. Jones, and B. F. Haynes Immunologic Characterization of CD7-Deficient Mice J. Immunol., June 15, 1998; 160(12): 5749 - 5756. [Abstract] [Full Text] [PDF]

				E. T. Lally, I. R. Kieba, A. Sato, C. L. Green, J. Rosenbloom, J. Korostoff, J. F. Wang, B. J. Shenker, S. Ortlepp, M. K. Robinson, et al. RTX Toxins Recognize a beta 2 Integrin on the Surface of Human Target Cells J. Biol. Chem., November 28, 1997; 272(48): 30463 - 30469. [Abstract] [Full Text] [PDF]

				A. Gonzalez-Garcia, I. Merida, C. Martinez-A, and A. C. Carrera Intermediate Affinity Interleukin-2 Receptor Mediates Survival via a Phosphatidylinositol 3-Kinase-dependent Pathway J. Biol. Chem., April 11, 1997; 272(15): 10220 - 10226. [Abstract] [Full Text] [PDF]